**Abstract**

**Objectives:** Over the past few decades, the complex treatment of chronic back pain includes a psychosomatic approach, focusing on the biopsychosocial model of chronic pain. Namely, a comprehensive assessment of physical, neurological and psychological state, their mutual influence and selection of therapy, that focuses on these characteristics.

A significant contribution to the understanding of chronic back pain as the disorder, having psychosomatic mechanisms that made successful use of antidepressants in the integrated treatment of such patients.

The aim of our study was to investigate the efficacy of selective serotonin reuptake inhibitor in patients with chronic back pain.

**Methods:** In this trial we used SSRI fluoxetin on 60 patients (42 women and 18 men) with chronic back pain in age from 45 till 60. Mostly the main cause of dorsalgia was chronic osteoporosis (80%). Patient received a drug once a day in a 20 mg dose for 6 weeks. Before start of trial all the patients discontinued using of NSAIDs. To evaluate the pain we used visual analog scale of pain.

**Results:** Using a SSRI fluoxetin has shown a very good results. 29 patients (48,3%) of patient have shown significant reducing of pain during treatment (decreasing of VAS from average 4.9 till 1.5), 28 patients (46,6%) have shown slightly less reducing of pain (decreasing of VAS from average 4.5 till 2.6), 3 patients (5%) quitted the trial in first week due to adverse effects (nausea, insomnia, sexual disorders).

**Conclusion:** In the end of trial all the patients continued to use the drug on their own. We can recommend to use SSRIs as a part of complex therapy of low back pain, due to its safety and high efficacy
